SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Priya C Singh, Samir K Ballas, Emerging drugs for sickle cell anemia, Expert Opinion on Emerging Drugs, 2015, 20, 1, 47

    CrossRef

  2. 2
    Claudia R. Morris, Alterations of the Arginine Metabolome in Sickle Cell Disease, Hematology/Oncology Clinics of North America, 2014, 28, 2, 301

    CrossRef

  3. 3
    P. Shi, N. Mohandas, Reference Module in Biomedical Sciences, 2014,

    CrossRef

  4. 4
    Danilo Grunig Humberto Silva, Edis Belini Junior, Eduardo Alves de Almeida, Claudia Regina Bonini-Domingos, Oxidative stress in sickle cell disease: An overview of erythrocyte redox metabolism and current antioxidant therapeutic strategies, Free Radical Biology and Medicine, 2013, 65, 1101

    CrossRef

  5. 5
    Begoña Ruiz-Núñez, Stéphanie A. De Rooij, Pieter J. Offringa, Gert E. Schuitemaker, Tom Teerlink, Hose S.M. Booi, Janneke D.A. Dijck-Brouwer, Frits A.J. Muskiet, Supplementation of patients with sickle cell disease with astaxanthin increases plasma- and erythrocyte-astaxanthin and may improve the hemolytic component of the disease, Free Radicals and Antioxidants, 2013,

    CrossRef

  6. 6
    D. Manwani, P. S. Frenette, Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies, Blood, 2013, 122, 24, 3892

    CrossRef

  7. 7
    D. Manwani, P. S. Frenette, Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies, Hematology, 2013, 2013, 1, 362

    CrossRef